The Federal government’s announcement of a deal with UK-based drug company AstraZeneca to lock in supply of a coronavirus vaccine should trials prove successful has disappointed local vaccine developers. Adelaide scientists have been working overtime on a different kind of new vaccine  – called COVAX-19 it has  shown promising results after clearing its first phase of human trials. In spite of this vaccine developer Professor Nikolai Petrovsky say he has been unable to interest the Australian government in the project.

Download Audio
Wednesday, August 19 2020
Produced By
Featured in storyProfessor Nikolai Petrovsky , Professor in the College of Medicine and Public Health at Flinders University. And Research Director of Vaxine Pty Ltd

The Wire is produced in partnership by

Contributor Stations

Supporters and Program Distribution